Skip to main content
. 2022 Jul 4;13:935500. doi: 10.3389/fphar.2022.935500

TABLE 4.

Comparison of HP and PDIA3 levels in patients with different TNM stages of colorectal cancer (x ± s). *vs. Stage I (p > 0.05),**vs. Stage III (p > 0.05).

TNM Staging Number of Cases HP (μl/ml) PDIA3 (ng/ml)
Stage I 21 156 ± 29 68 ± 15
Stage II 23 149 ± 26* 66 ± 14*
Stage III 30 173 ± 23 81 ± 15
Stage IV 14 183 ± 51** 80 ± 28**
P 0.004 0.005